All Activities
Choose from the criteria below to find an activity that fits you best.
Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information ►
Featured Activity
Contemporary Evaluation and Management of Lung Cancer Targeted Therapies
Learn about treatment options, treatment failure, associated adverse effects and more.
Choose from the criteria below to find an activity that fits you best.
SHOW SEARCH
![]() |
![]() |
![]() Login to SIDP to verify your membership, then follow the members only link to receive the discount. |
![]() |
A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) |
Adverse drug events and adverse drug reactions can have considerable clinical and economic costs because they can lead to emergency department visits, hospitalization, and prolongation of hospitalization. Pharmacists are ideal health care professionals to assist with adverse event surveillance and reporting. This activity will provide pharmacists with education on several topics surrounding post-marketing drug safety surveillance, with particular emphasis on how adverse event reports are reported, collected, and analyzed by the U.S. Food and Drug Administration. In addition, the strengths and limitations of post-marketing drug safety surveillance will be discussed. Finally, recent safety information related specifically to antimicrobial products will be reviewed.
The target audience for this activity includes pharmacists. At the completion of this activity, the participant will be able to:
Timothy Jancel, PharmD, MHS, BCPS-AQ ID, BCIDP
Division of Pharmacovigilance
Office of Surveillance and Epidemiology
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Silver Spring, MD
Release Date: 12-05-2019
Expiration Date: 12-05-2022
BCIDP Expiration: 12-05-2020
This activity is jointly provided by ProCE, Inc. and the Society of
Infectious Diseases Pharmacists. ProCE, Inc. is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal
Activity Number 0221-9999-19-528-H04-P has been assigned to this home study knowledge-based
activity (initial release date 12-5-2019). This activity is approved for 1.5 contact
hours (0.15 CEU) in states that recognize ACPE providers. Participants must complete
the online post-test and activity evaluation to receive pharmacy CE credit. No partial
credit will be given. Statements of completion will be issued online at www.ProCE.com,
and proof of completion will be posted in NABP CPE Monitor profiles.
The Society of Infectious Diseases Pharmacists (SIDP) is accredited
by the Board of Pharmacy Specialties (BPS) as a provider of board certified infectious
diseases pharmacist (BCIDP) credit. A BCIDP statement of credit will be issued online
upon successful completion of a post-test and online evaluation. The post-test must
be successfully completed in only one attempt. No partial credit will be given. BCIDP
accreditation begins 12/05/2019 for this activity and is available for one year from
this date.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Dr. Jancel has no relevant commercial or financial relationships to disclose.
This activity is provided by ProCE, Inc. and SIDP.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.